Medical Net, Inc. (TYO:3645)
241.00
-5.00 (-2.03%)
Jul 21, 2026, 3:30 PM JST
Medical Net Balance Sheet
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Equivalents | 1,956 | 1,456 | 1,528 | 1,518 | 1,133 |
Cash & Short-Term Investments | 1,956 | 1,456 | 1,528 | 1,518 | 1,133 |
Cash Growth | 34.34% | -4.71% | 0.66% | 33.98% | 30.53% |
Receivables | 1,048 | 884 | 834 | 674 | 649 |
Inventory | 363 | 318 | 206 | 123 | 129 |
Other Current Assets | 233 | 300 | 266 | 144 | 166 |
Total Current Assets | 3,600 | 2,958 | 2,834 | 2,459 | 2,077 |
Property, Plant & Equipment | 114 | 133 | 125 | 111 | 106 |
Long-Term Investments | 294 | 195 | 469 | 497 | 411 |
Goodwill | 376 | 394 | 446 | 293 | 462 |
Other Intangible Assets | 41 | 34 | 14 | 12 | 15 |
Long-Term Deferred Tax Assets | 98 | 75 | 58 | 49 | 34 |
Other Long-Term Assets | 2 | - | 2 | 2 | 2 |
Total Assets | 4,568 | 4,080 | 3,989 | 3,467 | 3,154 |
Accounts Payable | 397 | 408 | 436 | 322 | 259 |
Accrued Expenses | 34 | 21 | - | - | - |
Short-Term Debt | 1,086 | 846 | 530 | 680 | 630 |
Current Portion of Long-Term Debt | 68 | 69 | 112 | 27 | 32 |
Current Income Taxes Payable | 75 | 17 | 69 | 90 | 91 |
Other Current Liabilities | 529 | 570 | 475 | 318 | 288 |
Total Current Liabilities | 2,189 | 1,931 | 1,622 | 1,437 | 1,300 |
Long-Term Debt | 267 | 336 | 387 | 82 | 111 |
Pension & Post-Retirement Benefits | 44 | 40 | 40 | 11 | 5 |
Other Long-Term Liabilities | 4 | 6 | 10 | 9 | 2 |
Total Liabilities | 2,504 | 2,313 | 2,059 | 1,539 | 1,418 |
Common Stock | 286 | 286 | 286 | 286 | 286 |
Additional Paid-In Capital | 348 | 337 | 337 | 337 | 287 |
Retained Earnings | 1,709 | 1,598 | 1,693 | 1,710 | 1,634 |
Treasury Stock | -400 | -543 | -443 | -443 | -511 |
Comprehensive Income & Other | 50 | 37 | 33 | 26 | 11 |
Total Common Equity | 1,993 | 1,715 | 1,906 | 1,916 | 1,707 |
Minority Interest | 71 | 52 | 24 | 12 | 29 |
Shareholders' Equity | 2,064 | 1,767 | 1,930 | 1,928 | 1,736 |
Total Liabilities & Equity | 4,568 | 4,080 | 3,989 | 3,467 | 3,154 |
Total Debt | 1,421 | 1,251 | 1,029 | 789 | 773 |
Net Cash (Debt) | 535 | 205 | 499 | 729 | 360 |
Net Cash Growth | 160.98% | -58.92% | -31.55% | 102.50% | -25.93% |
Net Cash Per Share | 58.22 | 22.97 | 55.17 | 81.35 | 41.14 |
Filing Date Shares Outstanding | 9.25 | 9.27 | 9.05 | 9.05 | 8.82 |
Total Common Shares Outstanding | 9.25 | 8.73 | 9.05 | 9.05 | 8.82 |
Working Capital | 1,411 | 1,027 | 1,212 | 1,022 | 777 |
Book Value Per Share | 215.52 | 196.41 | 210.72 | 211.82 | 193.63 |
Tangible Book Value | 1,576 | 1,287 | 1,446 | 1,611 | 1,230 |
Tangible Book Value Per Share | 170.42 | 147.39 | 159.86 | 178.10 | 139.52 |